Treatment of urinary tract infections in condition of growing antibiotic resistance: Antimicrobial Stewardship program
Abstract
Resistance to common groups of antibiotics has been increasing in the treatment of urinary tract infections worldwide. In the United States, CDC has estimated that more thаn 2 million infections and 23,000 deaths are due to antibiotic resistance each year. In Europe, an еstimated 25,000 deaths are attributable to antibiotic-rеsistant infections. By 2050, it is estimated that antibiotic resistance will cause 10 million deaths every year.At the EU/EEA level, more than half (58.2%) of the E. coli isolates reported to EARS-Net for 2017 were resistant to at least one of the antimicrobial groups under regular surveillance, i.e. aminopenicillins, fluoroquinolones, third-generation cephalosporins, aminoglycosides and carbapenems. A majority (87.4%) of the third-generation cephalosporin-resistant E. coli isolates from 2017 were extended-spectrum beta-lactamase (ESBL)-positive.
Use of broad-spectrum antimicrobials is a known risk factor for colonization and spread of resistant Enterobacteriaceae, including E. coli. The high levels of ESBLs and increasing resistance to key antimicrobial groups might also lead to an increased consumption of carbapenems, which in turn can increase the selection pressure and facilitated the spread of carbapenem-resistant Enterobacteriaceae. According to annual reports of CDC, WHO, EARS-Net and others,estimate that 30 percent of all antibiotics prescribed in outpatient clinics and 40 percent of all antibiotics prescribed in inpatient clinics were unnecessary. Improving the way we use antibiotics, often referred to as «antibiotic stewardship», is part of the National Action Plan. Appropriate antibiotic use means using the right antibiotic, at theright dose, for the right duration, and at the right time.
The article reflects the recommendations of the European Association of Urology 2019 on the management and treatment of urinary tract infections in accordance with the principles of Antimicrobial Stewardship Program.
Downloads
References
4. American Urology Association. 2019. Available online: https://www.auanet.org/education/adult-uti.cfm
5. Kolesnik MО, Stepanova NM, Lebid LO, Stashevskyi NV, Busygin YS. Adapted clinical instruction for the better practice of diagnosis, treatment and prevention of urinary tract infections in women. Ukrainian Journal of Nephrology and Dialysis. 2012; 2(34): 53-77. Available from: https://ukrjnd.com.ua/index.php/journal/issue/view/12/2-34-2012-pdf [In Ukrainian].
6. Kolesnyk M, Dudar I, Stepanova N, Fomina S, Velichko M, Shifris I, et al. Classification of the urinary tract disease. Ukrainian Journal Of Nephrology and Dialysis, 2018; 1(57):3-23. Available from https://ukrjnd.com.ua/index.php/journal/issue/view/35/1-57-2018-pdf [In Ukrainian].
7. Kolesnik M.О., Lishchyshyna O.M., Ablohina O.V., Berezniak T.I., Bilenko O.V., Honchar Y.I. et al. “National registry of patients with chronic kidney disease”2014:126. Available from: http://mtd.dec.gov.ua/images/dodatki/2016_89_Peryt_dializ_dorosli/2016_89_AKN_XXN.pdf [In Ukrainian].
10. Centres for Disease Control and Prevention. available from: https://www.cdc.gov/drugresistance/resources/publications.html
11. Surveillance of antimicrobial resistance in Europe 2017. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2017. Stockholm: ECDC; 2018 Available from: https://ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2017
14. Ribero Pombo MH, Gandra S, Thompson D, Lamkang A, Pulcini C, Laxminarayan R. Global Core Standards for Hospital Antimicrobial Stewardship Programs: International Perspectives and Future Directions. Doha, Qatar: World Innovation Summit for Health, 2018. 52 p. Available from: https://cddep.org/publications/checklist-for-hospital-antimicrobial-stewardship-programming/
16.WHO report on surveillance of antibiotic consumption: 2016-2018 early implementation. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO. Available from https://www.who.int/medicines/areas/rational_use/who-amr-amc-report-20181109.pdf
17. Gelband H, et al. The state of the world's antibiotics 2015. Annual Report of World Health Organization. – 2015:84. Available online: https://cddep.org/sites/default/files/swa_2015_final.pdf
18. Annual report of CDC: Antibiotic Rx in Hospitals: Proceed with Caution (2014). Available from: https://www.cdc.gov/vitalsigns/antibiotic-prescribing-practices/index.html
19. Annual report of CDC: Stop Spread of Antibiotic Resistance (2015). Available from: https://www.cdc.gov/vitalsigns/stop-spread/index.html
20. Annual report of CDC: Protect Patients from Antibiotic Resistance (2016) Available from: https://www.cdc.gov/vitalsigns/protect-patients/index.html
21. Annual report of CDC: Antibiotic Stewardship Report (2017) Available from: https://www.cdc.gov/getsmart/stewardship-report/index.html
22. Annual report of CDC: Vital Signs Report: Containing Unusual Resistance (2018) Available from: https://www.cdc.gov/vitalsigns/containing-unusual-resistance/index.html
23. Bonkat (Chair) G, Bartoletti R R, Bruyère F, Cai T, Geerlings S E, Köves B, et al. Guidelines on Urological infections. European Association of Urology 2019: 60 p. Available from: https://uroweb.org/guideline/urological-infections/
